Clinical Pharmacology of Cefepime in Infants and Children
Cefepime is a fourth-generation cephalosporin which is approved in Europe and in the USA. Food and Drug Administration (FDA) approves cefepime in the treatment of febrile neutropenia. Cefepime is active against gram-negative microorganisms such as Escherichia coli, Haemophilus influenzae, Enterobact...
Main Authors: | Gian Maria Pacifici, Giovanna Marchini |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-04-01
|
Series: | International Journal of Pediatrics |
Subjects: | |
Online Access: | http://ijp.mums.ac.ir/article_8534_010551b15379e05ed683b121bb930dc9.pdf |
Similar Items
-
Clinical Pharmacology of Cefotaxime in Neonates and Infants: Effects and Pharmacokinetics
by: Gianmaria Pacifici, et al.
Published: (2017-11-01) -
Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-05-01) -
A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023-08-01) -
Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021-04-01) -
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
by: Po-Yu Liu, et al.
Published: (2022-10-01)